Tonix Pharm Hldg (TNXP) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharm Hldg (NASDAQ: TNXP) reported Q2 EPS of ($0.61), $0.08 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
